Skip to menu Skip to content Skip to footer
Associate Professor Brett Hughes
Associate Professor

Brett Hughes

Email: 

Overview

Background

Dr Brett Hughes graduated from the University of NSW with a Bachelor of Medical Science and Bachelor of Medicine and Surgery in 1997. He completed his postgraduate training in Canberra and Brisbane and was admitted as a Fellow of the Australian College of Physicians as a Specialist Medical Oncologist in 2005.

Dr Hughes is currently a Senior Staff Specialist Medical Oncologist at the RBWH and TPCH. He is also an Associate Professor at the University of Queensland since 2015. As the previous Clinical Director of Oncology (201-2017) and current Cancer Care Services Research lead at TPCH, Dr Hughes has established both an independent TPCH Oncology unit and continuing TPCH’s reputation as a lung cancer research centre of excellence.

Dr Hughes is an active senior member of the Thoracic Oncology Group Australasia (TOGA) and the Trans Tasman Radiation Oncology Group (TROG). He is also heavily involved in many pivotal multicentre trials of cancer therapy at both TPCH and RBWH with his principal research interests in Lung cancer, Head & Neck cancer, Mesothelioma, cutaneous SCC and Thyroid cancer. He has published over 100 peer review papers. Dr Hughes is also involved in undergraduate and post graduate teaching in his fields of research interest.

Availability

Associate Professor Brett Hughes is:
Available for supervision

Works

Search Professor Brett Hughes’s works on UQ eSpace

194 works between 2004 and 2025

141 - 160 of 194 works

2017

Journal Article

Investigation of p16 status, chemotherapy regimen and other nutrition markers for predicting gastrostomy in patients with head and neck cancer

Brown, Teresa E., Wittholz, Kym, Way, Mandy, Banks, Merrilyn D., Hughes, Brett G. M., Lin, Charles Y., Kenny, Lizbeth M. and Bauer, Judith D. (2017). Investigation of p16 status, chemotherapy regimen and other nutrition markers for predicting gastrostomy in patients with head and neck cancer. Head and Neck, 39 (5), 868-875. doi: 10.1002/hed.24630

Investigation of p16 status, chemotherapy regimen and other nutrition markers for predicting gastrostomy in patients with head and neck cancer

2017

Journal Article

Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years

Powell, J. T., Sweeting, M. J., Ulug, P., Blankensteijn, J. D., Lederle, F. A., Becquemin, J. P., Greenhalgh, R. M., Greenhalgh, R. M., Beard, J. D., Buxton, M. J., Brown, L. C., Harris, P. L., Powell, J. T., Rose, J. D.G., Russell, I. T., Sculpher, M. J., Thompson, S. G., Lilford, R. J., Bell, P. R.F., Greenhalgh, R. M., Whitaker, S. C., Poole-Wilson, P. A., Ruckley, C. V., Campbell, W. B., Dean, M. R.E., Ruttley, M. S.T., Coles, E. C., Powell, J. T., Halliday, A. ... Chand, P. (2017). Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. British Journal of Surgery, 104 (3), 166-178. doi: 10.1002/bjs.10430

Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years

2017

Journal Article

Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT ± concurrent chemotherapy

Moroney, Laura B., Helios, Jennifer, Ward, Elizabeth C., Crombie, Jane, Wockner, Leesa F., Burns, Clare L., Spurgin, Ann-Louise, Blake, Claire, Kenny, Lizbeth and Hughes, Brett G. M. (2017). Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT ± concurrent chemotherapy. Oral Oncology, 64, 1-8. doi: 10.1016/j.oraloncology.2016.11.009

Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT ± concurrent chemotherapy

2017

Conference Publication

Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)

Mauti, L., Rivalland, G., Klingbiel, D., Kao, S., Schmid, S., Nowak, A., Gautschi, O., Hughes, B., Bartnick, T., Pavlakis, N., Bouchaab, H., O'Byrne, K., Rothschild, S., Russell, P., Savic Prince, S., Thapa, B., Pless, M., von Moos, R., Metaxas, Y. and John, T. (2017). Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH). ESMO Immuno Oncology Congress 2017, Geneva, Switzerland, 7–10 December 2017. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdx711.007

Pembrolizumab (pembro) for relapsed malignant pleural mesothelioma (MPM): Outcomes in real-life setting in Australia (AUS) and Switzerland (CH)

2016

Journal Article

Comparison of nutritional and clinical outcomes in patients with head and neck cancer undergoing chemoradiotherapy utilizing prophylactic versus reactive nutrition support approaches

Brown, Teresa E., Banks, Merrilyn D., Hughes, Brett G. M., Lin, Charles Y., Kenny, Lizbeth M. and Bauer, Judith D. (2016). Comparison of nutritional and clinical outcomes in patients with head and neck cancer undergoing chemoradiotherapy utilizing prophylactic versus reactive nutrition support approaches. Journal of the Academy of Nutrition and Dietetics, 118 (4), 627-636. doi: 10.1016/j.jand.2016.10.013

Comparison of nutritional and clinical outcomes in patients with head and neck cancer undergoing chemoradiotherapy utilizing prophylactic versus reactive nutrition support approaches

2016

Journal Article

Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)

Barlesi, F., Dingemans, A. M.C., Yang, J. C.H., Ou, S. H.I., Ahn, J. S., De Petris, L., Hughes, B., Lena, H., Bordogna, W., Golding, S., Morcos, P. N., Balas, B., Zeaiter, A. and Kim, D. W. (2016). Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC). Annals of Oncology, 27 (S6), vi437. doi: 10.1093/annonc/mdw383.63

Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)

2016

Conference Publication

The Significance of Pulmonary Nodules in Head and Neck Cancer

Ladwa, R., Xu, W., Tani, D., Wockener, L., Williamson, K., Lwin, Z., Ritchie, A., Steinke, K. and Hughes, B. (2016). The Significance of Pulmonary Nodules in Head and Neck Cancer. HOBOKEN: WILEY-BLACKWELL.

The Significance of Pulmonary Nodules in Head and Neck Cancer

2016

Conference Publication

Lean Thinking: Exploring Overhead and Supplementary Tasks (Ost) in Cancer Care (Cc) in the Oncology Outpatient Encounter (Ooe)

Peters, G., Smith, D., Rasool, M., Ladwa, R., Hughes, B. and Lwin, Z. (2016). Lean Thinking: Exploring Overhead and Supplementary Tasks (Ost) in Cancer Care (Cc) in the Oncology Outpatient Encounter (Ooe). HOBOKEN: WILEY-BLACKWELL.

Lean Thinking: Exploring Overhead and Supplementary Tasks (Ost) in Cancer Care (Cc) in the Oncology Outpatient Encounter (Ooe)

2016

Journal Article

Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma

Hansen, Aaron R., Hughes, Brett G., Paul, Sanjoy, Steadman, Peter, Sommerville, Scott, Dickinson, Ian C., Walpole, Euan T., Thomson, Damien B., Mar Fan, Helen G. and Joubert, Warren L. (2016). Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma. Asia-Pacific Journal of Clinical Oncology, 12 (2), e222-e228. doi: 10.1111/ajco.12167

Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma

2016

Journal Article

Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: a phase II global study

Ou, Sai-Hong Ignatius, Ahn, Jin Seok, De Petris, Luigi, Govindan, Ramaswamy, Yang, James Chin-Hsin, Hughes, Brett, Lena, Herve, Moro-Sibilot, Denis, Bearz, Alessandra, Ramirez, Santiago Viteri, Mekhail, Tarek, Spira, Alexander, Bordogna, Walter, Balas, Bogdana, Morcos, Peter N., Monnet, Annabelle, Zeaiter, Ali and Kim, Dong-Wan (2016). Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: a phase II global study. Journal of Clinical Oncology, 34 (7), 661-668. doi: 10.1200/JCO.2015.63.9443

Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: a phase II global study

2016

Journal Article

Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer

Brown, T. E., Getliffe, V., Banks, M. D., Hughes, B. G. M., Lin, C. Y., Kenny L. M. and Bauer, J. (2016). Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer. European Journal of Clinical Nutrition, 70 (5), 1-8. doi: 10.1038/ejcn.2015.230

Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer

2016

Conference Publication

Pneumocystis pneumonia (Pjp) in lung cancer patients

Chavalertsakul, Nuttaya, Lwin, Zarnie, Hay, Karen and Hughes, Brett (2016). Pneumocystis pneumonia (Pjp) in lung cancer patients. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. HOBOKEN: WILEY-BLACKWELL.

Pneumocystis pneumonia (Pjp) in lung cancer patients

2016

Conference Publication

Understanding Initiation of Nutrition Support in Patients with Head and Neck Cancer (Hnc) and Adherence to Recommendations-A Patient Perspective

Brown, Teresa, Banks, Merrilyn, Hughes, Brett, Lin, Charles, Kenny, Lizbeth and Bauer, Judith (2016). Understanding Initiation of Nutrition Support in Patients with Head and Neck Cancer (Hnc) and Adherence to Recommendations-A Patient Perspective. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Understanding Initiation of Nutrition Support in Patients with Head and Neck Cancer (Hnc) and Adherence to Recommendations-A Patient Perspective

2016

Conference Publication

Nutrition Outcomes and Toxicities Following Helical-Intensity Modulated Radiotherapy (H-Imrt) in Patients with Head and Neck Cancer

Blake, Claire, Lai, Rainbow, Moroney, Laura, Helios, Jennifer, Hughes, Brett, Chua, Ben, Bauer, Judy and Brown, Teresa (2016). Nutrition Outcomes and Toxicities Following Helical-Intensity Modulated Radiotherapy (H-Imrt) in Patients with Head and Neck Cancer. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD, Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley.

Nutrition Outcomes and Toxicities Following Helical-Intensity Modulated Radiotherapy (H-Imrt) in Patients with Head and Neck Cancer

2015

Journal Article

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial

Davidson, A., Veillard, A. -S., Tognela, A., Chan, M. M. K., Hughes, B. G. M., Boyer, M., Briscoe, K., Begbie, S., Abdi, E., Crombie, C., Long, J., Boyce, A., Lewis, C. R., Varma, S., Broad, A., Muljadi, N., Chinchen, S., Espinoza, D., Coskinas, X., Pavlakis, N., Millward, M. and Stockler, M. R. (2015). A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial. Annals of Oncology, 26 (11) mdv373, 2280-2286. doi: 10.1093/annonc/mdv373

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: The Australasian lung cancer trials group NITRO trial

2015

Journal Article

Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer

Brown, Teresa E., Crombie, Jane, Spurgin, Ann-Louise, Tripcony, Lee, Keller, Jacqui, Hughes, Brett G. M., Dickie, Graeme, Kenny, Lizbeth Moria and Hodge, Robert A. (2015). Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer. Head and Neck, 38 Suppl 1, 1-9. doi: 10.1002/hed.24184

Improving guideline sensitivity and specificity for the identification of proactive gastrostomy placement in patients with head and neck cancer

2015

Journal Article

Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?

Blinman, Prunella, Hughes, Brett, Crombie, Catherine, Christmas, Tim, Hudson, Malcolm, Veillard, Anne-Sophie, Muljadi, Nick, Millward, Michael, Wright, Gavin, Flynn, Peter, Windsor, Morgan, Stockler, Martin and Mclachlan, Sue-Anne (2015). Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?. European Journal of Cancer, 51 (12) 9495, 1529-1537. doi: 10.1016/j.ejca.2015.05.022

Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile?

2015

Journal Article

Swallowing outcomes and PEG dependence in head and neck cancer patients receiving definitive or adjuvant radiotherapy +/− chemotherapy with a proactive PEG: a prospective study with long term follow up

Crombie, Jane M., Ng, Stephanie, Spurgin, Ann-Louise, Ward, Elizabeth C., Brown, Teresa E. and Hughes, Brett G. M. (2015). Swallowing outcomes and PEG dependence in head and neck cancer patients receiving definitive or adjuvant radiotherapy +/− chemotherapy with a proactive PEG: a prospective study with long term follow up. Oral Oncology, 51 (6) 3212, 622-628. doi: 10.1016/j.oraloncology.2015.03.006

Swallowing outcomes and PEG dependence in head and neck cancer patients receiving definitive or adjuvant radiotherapy +/− chemotherapy with a proactive PEG: a prospective study with long term follow up

2015

Journal Article

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

Chan, Bryan A. and Hughes, Brett G.M. (2015). Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future. Translational Lung Cancer Research, 4 (1), 36-54. doi: 10.3978/j.issn.2218-6751.2014.05.01

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

2015

Conference Publication

The Wau (weighted activity unit) effect: evaluating the cost of Drg (Diagnosis related group) coding

Tan, J. Y., Bennett, R., Power, J., Thompson, L., Hughes, B. and Lwin, Z. (2015). The Wau (weighted activity unit) effect: evaluating the cost of Drg (Diagnosis related group) coding. The Medical Oncology Group of Australia 2015 ASM, Pathways in Medical Oncology – The Path Less Travelled, Hobart, Australia, 5‐7 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

The Wau (weighted activity unit) effect: evaluating the cost of Drg (Diagnosis related group) coding

Funding

Current funding

  • 2024 - 2026
    From Pixels to Prognosis: Harnessing single-cell spatial analysis to predict and improve immunotherapy response in lung cancer
    Cure Cancer Early Career Research Grants
    Open grant
  • 2023 - 2026
    Developing a multi-omic, high-dimensional assessment of head and neck cancer
    Garnett Passe and Rodney Williams Memorial Foundation Conjoint Grant
    Open grant

Past funding

  • 2014 - 2016
    NITRO Trial: A randomised phase III trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer (NHMRC Project Grant administered by the University of Sydney)
    University of Sydney
    Open grant
  • 2013 - 2016
    Improving quality of life in high-risk cancer populations: a randomised trial of a structured intervention for head and neck cancer survivors
    NHMRC Project Grant
    Open grant

Supervision

Availability

Associate Professor Brett Hughes is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Developing predictive biomarkers for immunotherapy using deep spatial profiling

    Associate Advisor

    Other advisors: Associate Professor Arutha Kulasinghe

  • Doctor Philosophy

    The changing face of head and neck cancer: addressing and advancing best-practice nutritional care to improve outcomes for patients with human papillomavirus-associated disease

    Associate Advisor

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor Brett Hughes's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au